Are you really understanding risk? All of the risks? @choratio
There's still a lot that can go wrong. For example, the data for GVHD is great but what if the FDA has doubts about the ability of Lonza to manufacture cells at the same quality, time after time, in massive quantities? Or perhaps the data read outs show efficacy, but not so high as to justify the large cost of the treatment.
I've got plenty invested in MSB but I try not to oversimplify the risks involved.
MSB Trading - 2020, page-12911
-
- There are more pages in this discussion • 10,250 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |